Reaction

Retroperitoneal Haematoma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,168 reports · 60 co-occurring drugs

As of the last recalculation, Retroperitoneal Haematoma appears in 2,168 FAERS reports alongside 60 co-occurring drug terms. The strongest observed disproportionality signal is FONDAPARINUX SODIUM (PRR 90.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Fondaparinux Sodium	74	90.8	91.7
Enoxaparin Sodium	286	54.8	55.1
Heparin Sodium	64	46.0	46.2
Warfarin Sodium	136	30.0	30.1
Remdesivir	34	24.9	24.9
Warfarin	268	23.0	23.0
Dalteparin Sodium	24	22.0	22.1
Trimethoprim	26	21.4	21.5
Clopidogrel Bisulfate	167	16.9	16.9
Valganciclovir Hydrochloride Powder,	20	15.9	15.9
Prasugrel Hydrochloride	16	15.2	15.2
Cephalexin	31	13.9	14.0
Valganciclovir	27	13.9	13.9
Valganciclovir Hydrochloride	27	13.9	13.9
Ticagrelor	45	13.8	13.8
Rivaroxaban	252	13.0	13.0
Nebivolol	21	12.8	12.8
Cefazolin	12	12.7	12.7
Phytonadione	11	12.5	12.5
Indapamide	23	12.4	12.5
Clopidogrel	229	12.3	12.3
Cefepime Hydrochloride	20	12.0	12.0
Drs. Clotrimazole	14	11.7	11.7
Family Wellness Clotrimazole	14	11.7	11.7
Clotrimazole Topical	14	11.7	11.7
Alteplase	18	11.6	11.6
Basiliximab	14	11.5	11.5
Cefazolin Sodium	14	11.2	11.2
Clotrimazole	14	11.0	11.0
Apixaban	68	10.0	10.0
Meropenem	32	9.7	9.7
Cefepime	14	9.4	9.4
Norepinephrine Bitartrate	14	9.4	9.4
Norepinephrine	10	9.0	9.0
Nicotine Polacrilex Mini	13	8.4	8.4
Nicotine Polarilex	13	8.4	8.4
Ceftriaxone Sodium	32	8.1	8.1
Ceftriaxone	27	8.0	8.0
Metronidazole Topical	39	8.0	8.0
Nifedipine	38	7.9	7.9
Metronidazole	51	7.8	7.8
Piperacillin And Tazobactam	10	7.5	7.5
Digoxin	54	7.4	7.4
Atovaquone	6	7.2	7.2
Dabigatran Etexilate Mesylate	53	7.2	7.2
Clarithromycin	25	7.1	7.1
Daspone	7	6.9	6.9
Dapsone Gel, 5%	7	6.9	6.9
Dabigatran Etexilate	54	6.8	6.8
Piperacillin Sodium,Tazobactam Sodium	17	6.2	6.2
Oseltamivir	5	6.0	6.0
Nebivolol Hydrochloride	21	6.0	6.0
Eplerenone	8	6.0	6.0
Axicabtagene Ciloleucel	6	5.9	5.9
Velpatasvir And Sofosbuvir	6	4.5	4.5
Botulinum Toxin Type A	5	3.9	3.9
Buprenorphine Hydrochloride, Naloxone Hydrochloride	9	3.6	3.6
Sevelamer Carbonate	4	3.3	3.3
Emicizumab	4	3.1	3.1
Methoxy Polyethylene Glycol-Epoetin Beta	3	2.6	2.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.